Abstract
Estrogen receptor (ER)-positive breast cancer patients treated with tamoxifen are known to have an elevated risk of subsequent endometrial cancer. However, it is unclear if ER-negative patients also have a higher risk of endometrial cancer. This population-based study aims to evaluate whether breast cancer patients with distinctive ER and PR status possess differential risks in developing delayed endometrial malignancy. Data were obtained from the Surveillance, Epidemiology, and End Results program (1992-2009). Standardized incidence ratio (SIR) was calculated as the observed cases of endometrial cancers among breast cancer survivors compared with the expected cases in the general population. Data were stratified by latency periods, race, age, and calendar year of breast cancer diagnosis. We identified 2044 patients who developed a second primary endometrial cancer among 289,933 breast cancer survivors. The overall SIRs for subsequent endometrial cancers were increased in all of the four subtypes (ER+PR+, ER+PR-, ER-PR+, and ER-PR-) of breast cancer. SIR was increased for all latency periods except for the initial 6-11 months after breast cancer diagnosis. Stratifying by age of diagnosis, elevated SIRs in all ER/PR groups were ...Continue Reading
References
Feb 1, 1992·Fertility and Sterility·G I GorodeskiA Geier
Feb 19, 1994·Lancet·F E van LeeuwenF W Diepenhorst
Jun 19, 1996·Journal of the National Cancer Institute·R E CurtisJ F Fraumeni
Oct 8, 1999·Journal of the National Cancer Institute·L BernsteinL Ford
Feb 28, 2002·Cancer Letters·Hee Joon KangDong Young Noh
Sep 19, 2002·Journal of the National Cancer Institute·Deborah ThompsonUNKNOWN Breast Cancer Linkage Consortium
Jul 2, 2003·Cancer·Mark E Sherman, Susan S Devesa
Mar 3, 2005·Journal of the National Cancer Institute·Anthony J SwerdlowUNKNOWN British Tamoxifen Second Cancer Study Group
Mar 15, 2005·American Journal of Clinical Pathology·Mehrdad NadjiAzorides R Morales
Oct 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Xiaojiang CuiAdrian V Lee
Dec 27, 2006·Pathology Oncology Research : POR·Jawad KianiShahid Pervez
Jan 18, 2007·The Oncologist·Matthew J HayatBrenda K Edwards
Sep 19, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Emad A RakhaIan O Ellis
Jan 10, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Leen De MaeyerPatrick Neven
Feb 19, 2008·Lancet·Andrew G RenehanMarcel Zwahlen
Feb 28, 2008·Breast Cancer Research and Treatment·Sandra M SwainPatricia A Ganz
Mar 8, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael SchaapveldFlora E van Leeuwen
Feb 12, 2009·Breast Cancer Research and Treatment·Shuzhen LiuTorsten O Nielsen
Jun 4, 2010·The New England Journal of Medicine·Sandra M SwainNorman Wolmark
Aug 2, 2011·Lancet·C DaviesR Peto
Aug 9, 2011·Breast Cancer Research and Treatment·Madiha F Abdel-MaksoudTim E Byers
Jan 4, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sara J SchonfeldWilliam F Anderson
Apr 9, 2013·Gynecologic Oncology·Yakir SegevUNKNOWN Hereditary Breast Cancer Study Group
Jan 31, 2014·Breast Cancer Research and Treatment·Kristin N AndersonMaria Elena Martinez
Feb 25, 2014·Journal of Cancer·Ju-Yin ChenYi-Hsuan Hsiao
Mar 29, 2014·Breast Cancer Research and Treatment·Jianli ZhaoFengxi Su
Jun 7, 2014·Gynecologic Oncology·William M BurkeUNKNOWN Society of Gynecologic Oncology Clinical Practice Committee
Jul 11, 2014·American Journal of Epidemiology·Agnès FournierNathalie Chabbert-Buffet
Aug 5, 2014·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·C NgôUNKNOWN Gynecological Cancer Study Group of Institut Curie
Citations
Apr 17, 2018·Cancer Medicine·Min-Chi ChenChao-Yu Chen
Jan 12, 2019·Medicine·Yura LeeJong Won Lee
Dec 21, 2019·Archives of Gynecology and Obstetrics·Alexander HeinFalk C Thiel
Mar 21, 2018·Hormones & Cancer·Zhiyu LiShengrong Sun
Mar 20, 2019·International Journal of Clinical Oncology·Jin-Li WeiZhi-Min Shao
Jan 4, 2020·Breast Cancer Research and Treatment·Akemi T WijayabahuLusine Yaghjyan
Mar 5, 2021·Curēus·Sara PortelaGeorgios Theophilou
Oct 15, 2020·International Urology and Nephrology·Hao LiHong Li
May 19, 2021·Cancer·Hyuna SungAhmedin Jemal